Post-Doctoral Training Fellow/Higher Scientific Officer in the Cancer Pharmacology & Stress Response team

04/11/2018, 23:55

Cancer Therapeutics
Cancer Pharmacology & Stress Response (CPSR)
Full time
Fixed Term
2 years
£30,715 - £39,082
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

One Post-Doctoral Training Fellow (PDTF) or Higher Scientific Officer (HSO) position is available in the Cancer Research UK Cancer Therapeutics Unit (CRUK CTU) at The Institute of Cancer Research (ICR)   ( in Sutton, Surrey.

The CRUK CTU is a multidisciplinary 'bench to bedside' centre, dedicated to the discovery and development of novel therapeutics for the treatment of cancer. Our exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidate compounds to clinical development. Our team is studying cancer pharmacology and response of cancer cells to stress. It is located in well-equipped CTU laboratories in Sutton, South London, where we work in close collaboration with world-class chemists and drug metabolism specialists to develop new small molecules that target essential proteins involved in the development and progression of cancer.

The successful candidate will apply their knowledge of cancer biology as well as technical expertise in in-vitro and in-vivo assays to characterise candidate cancer drugs developed in collaboration with multidisciplinary teams of the CTU and our commercial partner. The successful candidate is expected to develop their drug research skills, as well as a broader understanding of drug discovery.

Knowledge, experience and achievement in an area of molecular and/or tumour biology essential. Prior experience and track record in the area of cell-division cycle and/or autophagy would be of advantage. Familiarity with pharmacological approaches to cancer is desirable. The successful applicant will have opportunities to develop additional skills in post. This is an ideal opportunity for an enthusiastic, committed biologist to make an important contribution to improved therapies for cancer patients, while gaining experience and training in drug discovery skills in an institute with a track record of successful drug discovery and development.

Appointment will be for 2 years in the first instance. Starting salary will be on The ICR Post-doctoral Training Fellow Pay Scale or ICR Higher Scientific Officer Pay Scale, dependent on qualifications and experience.

Further information can be found in the job description.

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates

This Program is closed to applications.